Midgard Science

Labs / Assays & in vitro testing

Lipum AB Press Releases

Umeå, Sweden · lipum.se

On your own

Free. Their own form.

Contact Lipum AB Press Releases directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Lipum AB is a clinical phase biopharmaceutical company in Umeå, Sweden, developing treatments for chronic inflammatory diseases. It works on the drug candidate SOL-116, a humanized monoclonal antibody evaluated for rheumatoid arthritis and other inflammatory diseases.

They take quote requests by email.

What they offer

  • Drug discovery and development

    Develops new treatments for chronic inflammatory diseases from discovery through clinical development.

  • Clinical development

    Advances drug candidates through clinical studies, including Phase I and Phase IIa development for SOL-116.

  • Biologic drug development

    Develops a humanized monoclonal antibody candidate targeting Bile Salt-Stimulated Lipase (BSSL).

What they work on

Modalities
Antibody
Species and models
healthy volunteers, patients with mild rheumatoid arthritis
Therapeutic areas
chronic inflammatory diseases, rheumatoid arthritis
Sites
Umeå, Sweden
Serves
nationally, internationally

Similar labs. 3C Therapeutics, Alphalyse, ARSI Canada Inc, enGenes

Found in a contract services directory. Listing built from lipum.se. Work here? Claim this listing.

Lipum AB Press Releases · Midgard Science